Clinica Universidad de Navarra

Futó vizsgálatok

• Még nem toboroz

  An international study evaluating diagnostic and theranostic agents in patients with solid tumors and brain metastases.

  2025-523824-39-01· 2. fázis· Medica Scientia Innovation Research S.L.· Forrás

• Még nem toboroz

  Local and Systemic Immune Modulation by Rilvegostomig (AZD2936) in the Treatment of Advanced Gastric Cancer (RILVE Project)

  NCT07788664· 2. fázis· Vall d'Hebron Institute of Oncology· Forrás

• Még nem toboroz

  A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma

  NCT07728188· 3. fázis· AbbVie· Forrás

• Még nem toboroz

  A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis

  2026-526404-71-00· 2. fázis· Agomab Spain S.L.U.· Forrás

• Toboroz

  Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease

  NCT07781644· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants with Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  2024-518365-10-00· 3. fázis· F. Hoffmann-La Roche AG· Forrás

• Toboroz

  To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis

  NCT07629583· 1. fázis· Genentech, Inc.· Forrás

• Még nem toboroz

  Elranatamab With Mezigdomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

  NCT07901868· 2. fázis· PETHEMA Foundation· Forrás

• Még nem toboroz

  A Phase 3 Open-Label, Randomized Controlled Trial of T-bren (BL-M07D1) vs. Platinum-based Chemotherapy in Patients with HER2-expressing metastatic urothelial cancer with disease progression on or after anti-PD-(L)1-based therapy

  2026-527617-29-00· 3. fázis· Systimmune Inc.· Forrás

• Még nem toboroz

  A First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma

  NCT07192471· 1. fázis· Kyowa Kirin Inc.· Forrás

• Toboroz

  A Study of RO7871996 in Participants with Systemic Lupus Erythematosus

  2026-527221-35-00· 1/2. fázis· F. Hoffmann-La Roche AG· Forrás

• Toboroz

  Phase 3 Study of Investigator Choice of Chemotherapy with or without Zoldonrasib as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma

  2025-524928-21-00· 3. fázis· Revolution Medicines Inc.· Forrás

• Még nem toboroz

  Phase 3 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC 6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma

  2025-524969-24-00· 3. fázis· Revolution Medicines Inc.· Forrás

• Még nem toboroz

  A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer

  NCT07711067· 2/3. fázis· ElmediX· Forrás

• Még nem toboroz

  Multicenter, open label, phase II clinical trial evaluating the combination of elranatamab with mezigdomide and dexamethasone in patients with relapsed/refractory multiple myeloma

  2026-526352-31-00· 2. fázis· Fundacion PETHEMA· Forrás

• Toboroz

  A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML

  NCT07751991· 1. fázis· Charm Therapeutics· Forrás

• Toboroz

  Study to Evaluate the Safety and Preliminary Efficacy of CD19 CAR-T Cell Therapy (TranspoCART19) in Patients With Refractory Lupus Nephritis

  NCT07799116· 1/2. fázis· Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz· Forrás

• Toboroz

  A Phase 3 Study Comparing Ramantamig plus Daratumumab Versus DVRd or DRd in Participants With NDMM for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy

  2026-526654-14-01· 3. fázis· Janssen Cilag International· Forrás

• Toboroz

  A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

  NCT07701941· 1/2. fázis· Daiichi Sankyo· Forrás

• Még nem toboroz

  A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies

  NCT07719348· 1/2. fázis· Servier· Forrás

• Toboroz

  A trial to learn how well AZD0120 works and how safe it is in people with relapsed or refractory multiple myeloma.

  2025-523285-25-00· 3. fázis· AstraZeneca AB· Forrás

• Még nem toboroz

  A Phase I First-in-Human Dose Escalation Trial to Evaluate the Safety and Efficacy of ARI-HER2 (HER2BBz CAR-T Cells) in Patients with HER2Positive Advanced Breast Cancer

  2026-527365-30-00· 1/2. fázis· Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer· Forrás

• Még nem toboroz

  A study to learn about the effects of Trontinemab in participants at risk for Alzheimer‘s disease

  2025-524314-29-00· 3. fázis· F. Hoffmann-La Roche AG· Forrás

• Toboroz

  Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer

  NCT07564141· 3. fázis· Genmab· Forrás

• Még nem toboroz

  Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.

  2026-525883-17-00· 3. fázis· Genmab A/S· Forrás

• Toboroz

  A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)

  NCT07636811· 2. fázis· Alnylam Pharmaceuticals· Forrás

• Még nem toboroz

  A Study to Evaluate the Efficacy and Safety of CP-012B in Participants With Parkinson’s Disease With Early Morning OFF Episodes

  2026-526634-46-00· 2. fázis· Contera Pharma A/S· Forrás

• Toboroz

  Phase 1/2 Multicenter, Open-label, Dose-escalation Study of IDP- 121 in Patients With Platinum-resistant Small Cell Lung Cancer (MYCrocytic)

  NCT07864207· 1/2. fázis· IDP Discovery Pharma S.L.· Forrás

• Fut, nem toboroz

  Phase II Open-Label, Single Arm, Multicenter Study of Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma

  2023-510560-12-00· 2. fázis· Fundacion Pethema· Forrás

• Toboroz

  A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

  2026-525234-39-00· 1. fázis· Janssen Cilag International· Forrás

• Toboroz

  Phase 1/2 multicenter, two-arms, open-label, dose-escalation study of IDP-121 in combination with chemotherapy in patients with relapsed small cell lung cancer (SCLC) (MYCrocytic)

  2025-521902-17-00· 1/2. fázis· Idp Discovery Pharma S.L.· Forrás

• Toboroz

  Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation

  NCT07575269· Boston Scientific Corporation· Forrás

• Toboroz

  A Phase 3 Randomized Study Comparing JNJ-79635322 versus Teclistamab in Participants with Relapsed or Refractory Multiple Myeloma

  2025-523815-12-00· 3. fázis· Janssen Cilag International· Forrás

• Még nem toboroz

  Optimizing the Use of Aspirin for the Prevention of Preeclampsia

  NCT07665853· 3. fázis· Hospital Universitari Vall d'Hebron Research Institute· Forrás

• Toboroz

  A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

  NCT07581002· 2/3. fázis· AbbVie· Forrás

• Toboroz

  A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell Lung Cancer

  2025-522818-23-00· 3. fázis· Zai Lab (US) LLC· Forrás

• Toboroz

  Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

  NCT07284602· 3. fázis· PureTech· Forrás

• Toboroz

  Grass Immunotherapy for Rhinitis and Asthma (GIRA)

  2025-521736-10-00· 3. fázis· LETI Pharma S.L.U.· Forrás

• Toboroz

  Grass/Olive Immunotherapy for Rhinitis and Asthma (GOES)

  2025-521709-42-00· 3. fázis· LETI Pharma S.L.U.· Forrás

• Toboroz

  Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

  NCT07555938· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease

  2025-524001-33-00· 2. fázis· Immunovant Sciences GmbH· Forrás

• Toboroz

  Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  NCT07562152· 3. fázis· Immuneering Corporation· Forrás

• Toboroz

  A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

  NCT07629960· 1/2. fázis· Blueprint Medicines Corporation· Forrás

• Toboroz

  A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

  NCT07518186· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Multi-centre Phase 1/2 study testing LB-208 for adults with relapsed/refractory AML or high-risk MDS

  2025-523396-38-00· 1/2. fázis· Aop Orphan Pharmaceuticals GmbH· Forrás

• Még nem toboroz

  A trial to learn how well AZD0120 works and about its safety in adults with newly diagnosed multiple myeloma

  2025-524014-29-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

  NCT07614776· 3. fázis· Amgen· Forrás

• Toboroz

  A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

  NCT07393282· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)

  NCT07570173· 2/3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

  NCT07582432· 3. fázis· Grifols Biologicals, LLC· Forrás

Showing 50 of 435.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák50 toboroz
• Mielóma multiplex40 toboroz
• Petefészekrák40 toboroz
• Hasnyálmirigyrák23 toboroz
• Prosztatarák22 toboroz
• Vastagbélrák21 toboroz
• Akut mieloid leukémia (AML)20 toboroz
• Máj- és epeúti rák18 toboroz
• Gyermekkori daganatok17 toboroz
• Mielodiszplasztikus szindróma (MDS)17 toboroz
• Áttétes emlőrák15 toboroz
• Gyomor- és nyelőcsőrák12 toboroz
• Lupus (SLE)12 toboroz
• Hodgkin-limfóma11 toboroz
• Tripla negatív emlőrák11 toboroz
• Hólyagrák10 toboroz
• Krónikus limfoid leukémia (CLL)10 toboroz
• Fej-nyaki daganatok9 toboroz
• Méhtestrák9 toboroz
• Dermatomyositis and polymyositis (myositis)8 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)8 toboroz
• Follikuláris limfóma8 toboroz
• Immune thrombocytopenia (ITP)7 toboroz
• Krónikus mieloid leukémia (CML)6 toboroz
• Melanóma6 toboroz
• Alzheimer-kór5 toboroz
• Graves' disease and hyperthyroidism4 toboroz
• IgA-nefropátia4 toboroz
• Köpenysejtes limfóma4 toboroz
• Vesedaganat4 toboroz
• Akut limfoid leukémia (ALL)3 toboroz
• Amiloidózis3 toboroz
• Időskori makuladegeneráció3 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)3 toboroz
• Krónikus vesebetegség3 toboroz
• Parkinson-kór3 toboroz
• Asztma2 toboroz
• Bronchiectasis2 toboroz
• Cisztás fibrózis2 toboroz
• Idiopátiás tüdőfibrózis2 toboroz
• Mezotelióma2 toboroz
• Neuroendokrin daganatok2 toboroz
• Pitvarfibrilláció2 toboroz
• Rheumatoid arthritis2 toboroz
• Szarkóma2 toboroz
• Szisztémás szklerózis (szkleroderma)2 toboroz
• Zsírmáj (MASLD/MASH)2 toboroz
• Depresszió1 toboroz
• Down syndrome1 toboroz
• Elhízás1 toboroz
• Essential tremor1 toboroz
• Glioblasztóma1 toboroz
• Hearing loss1 toboroz
• Magas vérnyomás1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Myasthenia gravis1 toboroz
• Pajzsmirigyrák1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Skizofrénia1 toboroz

Lezárt vizsgálatok

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis

  NCT07224672· 2. fázis· GlaxoSmithKline· Forrás

• Lezárult

  A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC

  2025-522867-13-00· 2. fázis· Merus B.V.· Forrás

• Toboroz

  A Phase IIb study to evaluate the effect of combination of dapagliflozin and baxdrostat compared with baxdrostat alone in participants with chronic kidney disease and high blood pressure

  2025-522407-23-00· 2. fázis· AstraZeneca AB· Forrás

• Visszavonták

  Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer

  NCT07353957· 2. fázis· Genmab· Forrás

• Lezárult

  A clinical trial to learn about the effects of VHB937 in people with Alzheimer's disease

  2024-516966-12-00· 2. fázis· Novartis Pharma AG· Forrás

• Toboroz

  A Phase 1/2a Study of UCART20x22 in B-Cell Non-Hodgkin Lymphoma [NatHaLi-01]

  NCT05607420· 1/2. fázis· Cellectis· Forrás

• Toboroz

  Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  NCT07214779· 3. fázis· Incyte Corporation· Forrás

• Lezárult

  Study of the Effectiveness and Safety of Acasunlimab Alone or With Pembrolizumab in treating Advanced Melanoma of the Skin That Has Returned After or did not respond to Cancer Immunotherapy (ABBIL1TY MELANOMA-07)

  NCT06984328· 2. fázis· Genmab A/S· Forrás

• Lezárult

  A study of AZD2962, an IRAK4 inhibitor, in Participants with Haematologic Neoplasms

  2025-520786-44-00· 1/2. fázis· AstraZeneca AB· Forrás

• Lezárult

  A Phase 1/2 Study of DCC-3116 in Patients With MAPK Pathway Mutant Solid Tumors

  NCT04892017· 1/2. fázis· Deciphera Pharmaceuticals Inc.· Forrás

• Lezárult

  A trial to learn how safe AZD0022 is, how well it works, and how it moves throughout the body over time in adults with tumors that have a KRAS-G12D mutation, when given alone and with other cancer drugs

  NCT06599502· 1/2. fázis· AstraZeneca AB· Forrás

• Lezárult

  Study of Repotrectinib and CYP450 probe Cocktail in Patients with locally advanced or Metastatic Tyrosine Kinase Inhibitors (TKI)-Pretreated ROS1-Positive Non-small Cell Lung Cancer (NSCLC)

  NCT05828303· 1. fázis· Bristol-Myers Squibb Services Unlimited Company· Forrás

• Lezárult

  A trial to learn how well NMS-01940153E works in combination with atezolizumab and priming administration of decitabine or with atezolizumab alone in patients with hepatocellular carcinoma (HCC) that cannot be removed by surgery and who received prior treatment with other anti-cancer medicines

  2024-516737-12-00· 2. fázis· Nerviano Medical Sciences S.r.l.· Forrás

• Lezárult

  Effect of a Postbiotic Intake on Glucose Control and Microbiota Composition of Type 2 Diabetic Subjects: a Randomized Controlled Trial.

  NCT06448182· Clinica Universidad de Navarra, Universidad de Navarra· Forrás

• Fut, nem toboroz

  A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma

  NCT06604715· 1. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia

  2024-511057-22-00· 3. fázis· Janssen Cilag International· Forrás

• Lezárult

  A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

  NCT06534411· 3. fázis· Novo Nordisk A/S· Forrás

• Leállították

  A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer

  NCT06516510· Korai 1. fázis· Blue Earth Therapeutics Ltd· Forrás

• Lezárult

  Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

  NCT06433219· 2. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  Effect of Copper CU64 PSMA I&T scanning to detect potential disease spread to lymph nodes in men with newly diagnosed Prostate Cancer

  2024-512754-16-01· 3. fázis· Curium US LLC· Forrás

• Leállították

  LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)

  NCT06558799· 2. fázis· NovoCure GmbH· Forrás

• Fut, nem toboroz

  RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms

  NCT06243458· 2. fázis· GCP-Service International West GmbH· Forrás

• Lezárult

  FOCALFLEX (CE Mark) Study

  NCT06271967· Abbott Medical Devices· Forrás

• Lezárult

  Clinical Trial Using Humanized CART Directed Against BCMA (ARI0002h) in Patients With Relapsed/​Refractory Multiple Myeloma to Proteasome Inhibitors, Immunomodulators and Anti-CD38 Antibody

  NCT04309981· 2. fázis· Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer· Forrás

• Lezárult

  Study to assess the safety, pharmacokinetics and efficacy of HMPL-523 in patients with Immune Thrombocytopenia

  2023-508819-23-00· 1. fázis· Hutchmed Ltd.· Forrás

• Lezárult

  A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)

  2023-506185-31-00· 2/3. fázis· Pliant Therapeutics Inc.· Forrás

• Lezárult

  A study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer (including fallopian tube or primary peritoneal cancers) expressing FOLR1

  NCT05870748· 2. fázis· Sutro Biopharma Inc.· Forrás

• Fut, nem toboroz

  ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer

  NCT06328738· 1. fázis· Enliven Therapeutics· Forrás

• Lezárult

  A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

  NCT06384547· 3. fázis· Viridian Therapeutics, Inc.· Forrás

• Lezárult

  A Phase 2 Trial of BDC-1001 as Single Agent and in Combination with Pertuzumab in Subjects with Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Previously Treated with Trastuzumab Deruxtecan

  NCT05954143· 2. fázis· Bolt Biotherapeutics Inc.· Forrás

• Lezárult

  EndoNAFLD: Relationship Between Fatty Liver Disease and Cardiovascular Diseases

  NCT06392828· IMDEA Food· Forrás

• Lezárult

  Feasibility Study on the FARAVIEW Technology

  NCT06175234· Boston Scientific Corporation· Forrás

• Visszavonták

  The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

  NCT06291415· 1. fázis· Hutchmed· Forrás

• Lezárult

  NXP800 in subjects with Ovarian Cancer

  NCT05226507· 1. fázis· Nuvectis Pharma Inc.· Forrás

• Lezárult

  A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments

  NCT06323928· 2. fázis· H. Lundbeck A/S· Forrás

• Lezárult

  Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine

  NCT06241313· 3. fázis· AbbVie· Forrás

• Lezárult

  Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

  NCT06119217· 2. fázis· Trishula Therapeutics, Inc.· Forrás

• Lezárult

  A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors

  NCT05109975· 1. fázis· Debiopharm International S.A.· Forrás

• Lezárult

  A Trial to Investigate TransCon TLR7/8 Agonist in Combination with Pembrolizumab, TransCon TLR7/8 Agonist in Combination with TransCon IL-2 β/γ, or Pembrolizumab Monotherapy as Neoadjuvant Therapy in Participants with Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)

  2023-506092-10-00· 2. fázis· Ascendis Pharma Oncology Division A/S· Forrás

• Lezárult

  A Phase 3 Study to Evaluate the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants with Relapsed or Refractory Multiple Myeloma (RRMM)

  2023-509472-42-00· 3. fázis· Celgene International II S.a.r.l.· Forrás

• Lezárult

  GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer

  2022-502453-33-00· 2. fázis· Genmab A/S· Forrás

• Lezárult

  THE ANTES B+ STUDY: AN OPEN-LABEL, PRAGMATIC, RANDOMIZED, CONTROLLED TRIAL OF TRIPLE THERAPY VERSUS LABA-LAMA COMBINATION TO IMPROVE CLINICAL CONTROL IN HIGH-RISK GOLD B PATIENTS (B+)

  2023-507304-32-00· 4. fázis· Fundacio Privada Mon Clinic Barcelona· Forrás

• Leállították

  Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML

  NCT06268574· 2. fázis· Ryvu Therapeutics SA· Forrás

• Lezárult

  A Multicenter, Open-Label Clinical Trial of RVU120 in Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia with or without NPM1 Mutation (RIVER-52)

  2023-505910-10-00· 2. fázis· Ryvu Therapeutics S.A.· Forrás

• Lezárult

  Phase 1b safety study of xevinapant, weekly cisplatin, and radiotherapy in participants with unresected LA SCCHN

  2023-505796-76-00· 1. fázis· Merck Healthcare KGaA· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

  NCT06224348· 3. fázis· Sanofi· Forrás

• Lezárult

  (VELA) Study of BLU-222 in Advanced Solid Tumors

  NCT05252416· 1/2. fázis· Blueprint Medicines Corp.· Forrás

• Toboroz

  A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

  NCT06091254· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Lezárult

  A Study to Evaluate Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants with Relapsed or Refractory Multiple Myeloma

  2023-503689-21-00· 1/2. fázis· F. Hoffmann-La Roche AG· Forrás

• Fut, nem toboroz

  A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)

  NCT06113445· 3. fázis· Incyte Corporation· Forrás

Showing 50 of 219.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Mielóma multiplex88 munka · 95 vizsgálat
• Petefészekrák37 munka · 53 vizsgálat
• Migrén17 munka · 5 vizsgálat
• Diffúz nagy B-sejtes limfóma (DLBCL)9 munka · 16 vizsgálat
• Mielodiszplasztikus szindróma (MDS)7 munka · 23 vizsgálat
• Follikuláris limfóma6 munka · 13 vizsgálat